FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to novel derivatives of aminoalkylpyridines of the general formula (I): wherein n means a whole number from 1 to 4; R1 represents hydrogen atom, hydroxyl group or lower (C1-C6)-alkoxy-group; R2 represents hydrogen atom or lower (C1-C6)-alkyl group with linear or branched chain; X represents hydrogen atom, fluorine atom, chlorine atom, bromine atom, hydroxyl group, trifluoromethyl group, 3,4-di-Cl, 2,4-di-Cl or lower (C1-C6)-alkoxy-group, or salts of these compounds as products of adding physiologically acceptable acid. Also, invention relates to a pharmaceutical composition based on these compounds inhibiting biosynthesis of cholesterol. Also, invention considers using abovementioned compounds in preparing pharmaceutical composition and to a method for synthesis of compounds of the formula (I). Invention provides synthesis of novel compounds possessing valuable biological properties and preparing pharmaceutical composition based on thereof.
EFFECT: improved preparing method, valuable medicinal properties of compounds and pharmaceutical composition.
10 cl, 12 dwg, 5 ex
Title |
Year |
Author |
Number |
PYRAZOLE COMPOUNDS AS SIGMA RECEPTOR INHIBITORS |
2011 |
- Garsija Lopes Monika
- Torrens Khover Antoni
- Dias Fernandes Khose Luis
- Kaamano Moure Ana Marija
|
RU2582338C2 |
BICYCLICAL NITROGEN-CONTAINING HETEROCYCLES AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF |
1999 |
- Kharris Uill'Jam
- Khill Kristofer Khu
- Smit Ajan Ehduard Dejvid
|
RU2256662C2 |
DERIVATIVES OF 6-ARYLPYRIDO[2,3-D]PYRIMIDINES AND -NAPHTHYRIDINES, PHARMACEUTICAL COMPOSITION SHOWING INHIBITORY EFFECT ON CELLULAR PROLIFERATION INDUCED BY PROTEIN TYROSINE KINASE AND METHOD OF INHIBITION OF CELLULAR PROLIFERATION |
1995 |
- Blanklej Klifton Dzhon
- Doehrti Annet Mehriehn
- Khambej Dzhejms Marino
- Panek Robert Li
- Shreder Mehl Konrad
- Shovol'Ter Khovard Dehniel' Khollis
- Konneli Klio
|
RU2191188C2 |
DERIVATIVES OF N-(3-AMINOPROPYL)-N-PHENYL-5,6,7,8-TETRAHYDRO- -NAPHTHALENE-2-CARBOXAMIDE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION |
1995 |
- Zhorzh Paskal'
- Frost Dzhonatan
- Paso Patrik
- Russel' Korinn
- Barch Rezhin
- Vil'Jams Pol Khauard
- Mjuller Zhan-Klod
|
RU2138479C1 |
METHOD OF PRODUCING 1-OXY OR 1,1-DIOXY 3,4-DI-SUBSTITUTED 1,2,5-THIADIAZOLES OR ACID-ADDITIVE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF |
0 |
- Ronni Rej Krenshou
- Aldo Antonio Aldzheri
|
SU1396967A3 |
NOVEL CARBOXY-SUBSTITUTED CYCLIC DERIVATIVES OF CARBOXAMIDE |
1997 |
- Burkkhol'Der Timoti P.
- Mejnard Dzhordzh D.
- Kudlach Ehlizabet M.
|
RU2199535C2 |
METHOD FOR PRODUCTION OF MEVALONELACTONE DERIVATIVES |
1989 |
- Esikhiro Fudzikava[Jp]
- Mikio Suzuki[Jp]
- Khirosi Ivasaki[Jp]
- Mitsuaki Sakasita[Jp]
- Masaki Kitakhara[Jp]
|
RU2045529C1 |
SIGMA-RECEPTOR INHIBITORS |
2005 |
- Korbera Arkhona Khordi
- Kuberes-Altisent Marija Rosa
- Kholents Jorg
- Martines-Ol'Mo Daniehl'
- Van'O-Domenech David
|
RU2404972C2 |
METHOD OF PRODUCING DERIVATIVES OF 1.2-DIAMINOCYCLOBUTENE-3.4-DION OR CHLOROHYDRATES THEREOF |
0 |
- Aldo Antonio Aldzheri
- Ronni Rej Krensho
|
SU1375127A3 |
3R,5S-(+)-7-[4- (4-FLUOROPHENYL) -2,6-DIISOPROPYL-5- METHOXYMETHYL- PYRID-3-YL] -3,5- DIHYDROXYHEPTENOIC ACID IN ERYTHRO-(E)-CONFIGURATION IN THE FORM OF PHYSIOLOGICALLY TOLERATED METAL SALT AS AN INHIBITOR OF CHOLESTEROL BIOSYNTHESIS |
1991 |
- Rol'F Angerbauer[De]
- Peter Faj[De]
- Val'Ter Khjubsh[De]
- Tomas Filipps[De]
- Khil'Mar Bishoff[De]
- Diter Pettsinna[De]
- Del'F Shmidt[De]
- Gjunter Tomas[De]
|
RU2026290C1 |